Home

TIMOTHY J BARBERICH

CIK 1120355 · Executive Chairman · last filed 2023-12-21

TIMOTHY J BARBERICH is an Executive Chairman who has filed 85 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing shows the insider bought $142.5K of TCRX on Dec 21, 2023. Across all open-market trades the lifetime net is −$33.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $170.2K across reported positions. 40 SEC filings were submitted jointly with SEPRACOR INC /DE/.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$170.2K

Companies

8

Total Filings

85

Lifetime Open-Market Net

-$33.24M

Filer Profile

Reported Address
40 ELM ST
CONCORD, MA 01752
State of Incorporation
DE
Related Filers
SEPRACOR INC /DE/ — 40 joint filings, latest 2009-10-22
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TCRX Director 99,969 $0.32 $31.8K $242.0K 5 2023-12-21
Korro Bio, Inc. (FREQ) Delisted Director 3,655 $14.98 $54.8K $0 5 2022-08-19
VSTM Director 18,167 $7.62 $138.4K $813.6K 13 2021-06-30
ROCKET PHARMACEUTICALS, INC. (ITEK) Delisted Director — — — $0 2 2017-06-21
HeartWare International, Inc. (HTWR) Delisted Director 0 — — $195.5K 17 2016-08-24
Eledon Pharmaceuticals, Inc. (TKAI) Delisted Director 13,453 — — $0 3 2016-06-16
BIOSPHERE MEDICAL INC (BSMD) Delisted Director 0 — — $0 6 2010-09-10
SEPRACOR INC /DE/ (SEPR) Delisted Director 526,598 — — -$34.49M 29 2009-10-19

Recent Filings

85 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-12-21 TCRX Buy (P) +29,147 $142.5K EDGAR
2023-06-15 TCRX Grant (A) — $0 EDGAR
2023-06-06 TCRX Buy (P) +37,880 $99.6K EDGAR
2022-08-19 Korro Bio, Inc. (FREQ) Delisted Mixed — $0 EDGAR
2022-06-23 Korro Bio, Inc. (FREQ) Delisted Grant (A) — $0 EDGAR
2022-06-03 TCRX Grant (A) — $0 EDGAR
2021-07-22 TCRX Conv (C) +33,259 $0 EDGAR
2021-06-30 VSTM Grant (A) — $0 EDGAR
2021-06-21 Korro Bio, Inc. (FREQ) Delisted Grant (A) — $0 EDGAR
2020-12-07 VSTM Buy (P) +50,000 $108.5K EDGAR
Showing 1–10 of 85
Page 1 of 9
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.